Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Issue Archive
Events
MM&M Awards 2012
Webcasts
MM&M Virtual Summit
Whitepapers
Directories
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
News
> Pfizer stop-smoking pill latest advertiser on video network
Pfizer stop-smoking pill latest advertiser on video network
Marc Iskowitz
November 25, 2009
Print
Email
Reprint
Permissions
Text:
A
|
A
|
A
A Chantix banner ad accompanies health-related videos from HealthiNation
More News
Komen, caught up in the culture wars, nurses damaged brand
Allergan scrubs some doc-payment data, spares med-ed grants
Jobson Medical files for chapter 11 debt relief
Merck results buoyed by sales of Januvia franchise
AstraZeneca announces more layoffs, Q4 results
RELATED TOPICS
DTC
Education & Awareness
Media
Company
Pfizer
Chantix became the latest pharmaceutical advertised on the HealthiNation health-video network, with the brand's banner ad running beneath clips on quitting smoking and losing weight.
The ad for Pfizer's smoking-cessation drug appears in a pop-out player launched when viewers opt to watch Better You, an original series of health-related episodes HealthiNation launched on its website last week.
HealthiNation CEO Raj Amin told
MM&M
that Better You gives viewers “a great place to start making healthier choices.”
The pharmaceutical ad can also be seen on other websites throughout the HealthiNation network, including USNews.com. Pfizer sold $846 million worth of Chantix (varenicline) in 2008, and analysts expect sales to come in lower this year.
As HealthiNation grows its distribution base both online and on television, several pharmaceutical-related advertisers have signed on. A banner ad and two-minute, conversational-style commercial for NuvaRing, a vaginal contraceptive device, appear during a series of online women's health-oriented programs called Girl Talk.
Bristol-Myers Squibb and Sanofi-Aventis run a promotion for anticoagulant Plavix, aired against heart disease-related programming featured on HealthiNation's cable television network, which includes nine cable operators. Cable customers have access to HealthiNation On Demand episodes through content-sharing deals.
Separately, HealthiNation said it recently signed two other content deals, one with AT&T to make health videos available to AT&T U-Verse TV subscribers for free, and the other with online healthcare ratings site HealthGrades, offering videos covering specific health conditions as part of that site's user experience.
“Advertisers can work with HealthiNation to deliver their message to a qualified audience across our partner network online and on television, increasing brand relevance and ultimately being a part of the consumer dialogue around important health issues,” said Amin.
Please enable JavaScript to view the
comments powered by Disqus.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MM&M Awards Photos
Most Popular
Most Emailed
Most Recent
Elsevier begins outreach as push-back on publisher threatens to widen
Bydureon approval a shot across bow for Victoza
P&G signals plans to cut ad costs by shifting to digital media
Jobson Medical files for chapter 11 debt relief
Patient Education: Vying for Attention
FDA study casts doubt on danger of "distracting visuals"
Generics makers approach a cliff of their own
MM&M Therapeutic Focus: Cardiovascular
AstraZeneca announces more layoffs, Q4 results
DDR on DTC: Spiriva
Jobson Medical files for chapter 11 debt relief
Elsevier begins outreach as push-back on publisher threatens to widen
P&G signals plans to cut ad costs by shifting to digital media
Bydureon approval a shot across bow for Victoza
Generics makers approach a cliff of their own
Merck results buoyed by sales of Januvia franchise
FDA study casts doubt on danger of "distracting visuals"
Allergan scrubs some doc-payment data, spares med-ed grants
MM&M Therapeutic Focus: Cardiovascular
Ernst & Young's Buck Luce named HBA Woman of the Year
Komen, caught up in the culture wars, nurses damaged brand
Allergan scrubs some doc-payment data, spares med-ed grants
Jobson Medical files for chapter 11 debt relief
A new test to identify Down Syndrome
Making a political football out of Plan B
Med Ed Report briefs
Merck results buoyed by sales of Januvia franchise
AstraZeneca announces more layoffs, Q4 results
Docs, patients and pharma
Ernst & Young's Buck Luce named HBA Woman of the Year
Popular Topics
Adherence
Advertising
Approval
Brand
CME
Companion Diagnostics
Corporate Reputation
DDMAC
Digital
Direct To Consumer (DTC)
DTC
Earnings
FDA
Financial
Generic
Guidance
Launch
Loyalty Program
Magazine
Major Statement
Manufacturing
Med Ed
Media
Regulatory
Television